share_log

180 Life Sciences | 3: Initial statement of beneficial ownership of securities-Director JIMENEZ OMAR

SEC announcement ·  Mar 12 05:23
Summary by Futu AI
Omar Jimenez, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that no securities are beneficially owned by Jimenez. The form, signed on March 11, 2024, is a standard disclosure for individuals in significant positions within publicly traded companies, and it is used to report any direct or indirect ownership of the company's securities. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Omar Jimenez, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that no securities are beneficially owned by Jimenez. The form, signed on March 11, 2024, is a standard disclosure for individuals in significant positions within publicly traded companies, and it is used to report any direct or indirect ownership of the company's securities. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.